NCT01068964 - Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension | Biotech Hunter

Enrollment

235

Participants

Timeline

Start Date

February 1, 2010

Primary Completion Date

September 1, 2010

Study Completion Date

September 1, 2010

Conditions

Open-angle GlaucomaOcular Hypertension

Interventions

DRUG

0.03% Bimatoprost/0.5% Timolol Ophthalmic Solution

One drop from each bottle, administered once daily in the evening for 4 weeks Bottle 1: 0.03% Bimatoprost/0.5% Timolol Ophthalmic Solution Bottle 2: Vehicle Ophthalmic Solution

DRUG

0.03% Bimatoprost Ophthalmic Solution and 0.5% Timolol Ophthalmic Solution

One drop from each bottle, administered once daily in the evening for 4 weeks Bottle 1: 0.03% Bimatoprost Ophthalmic Solution Bottle 2: 0.5% Timolol Ophthalmic Solution

Trial Locations (1)

Unknown

Beijing